Rose Marie Amini

Summary

Affiliation: Uppsala University
Country: Sweden

Publications

  1. ncbi request reprint A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
    Rose Marie Amini
    Department of Oncology and Regional Oncological Centre, University Hospital of Uppsala, Sweden
    Eur J Haematol 68:225-32. 2002
  2. pmc Mast cells and eosinophils in invasive breast carcinoma
    Rose Marie Amini
    Department of Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
    BMC Cancer 7:165. 2007
  3. ncbi request reprint Relationship between Hodgkin's and non-Hodgkin's lymphomas
    Rose Marie Amini
    Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden
    Med Oncol 20:211-20. 2003
  4. ncbi request reprint A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma
    Rose Marie Amini
    Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, SE 751 85 Uppsala, Sweden
    Leuk Lymphoma 43:2179-89. 2002
  5. ncbi request reprint Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival
    Rose Marie Amini
    Department of Genetics and Pathology, University of Uppsala, Sweden
    Leuk Lymphoma 43:1253-60. 2002
  6. ncbi request reprint Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
    Ingrid Glimelius
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University Hospital, Uppsala, Sweden
    Eur J Haematol 71:327-33. 2003
  7. ncbi request reprint Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
    Mattias Berglund
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Mod Pathol 18:1113-20. 2005
  8. ncbi request reprint IL-9 expression contributes to the cellular composition in Hodgkin lymphoma
    Ingrid Glimelius
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
    Eur J Haematol 76:278-83. 2006
  9. doi request reprint Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study
    Ingrid Glimelius
    Department of Radiology, Oncology and Radiation Science Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
    Eur J Haematol 87:208-16. 2011
  10. doi request reprint Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
    Norafiza Zainuddin
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
    Leuk Res 35:438-43. 2011

Detail Information

Publications27

  1. ncbi request reprint A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
    Rose Marie Amini
    Department of Oncology and Regional Oncological Centre, University Hospital of Uppsala, Sweden
    Eur J Haematol 68:225-32. 2002
    ..Our aims were to evaluate the response to salvage treatment in relation to initial treatment and to evaluate prognostic factors at the time of relapse in an unselected population of relapsing patients with Hodgkin's lymphoma (HL)...
  2. pmc Mast cells and eosinophils in invasive breast carcinoma
    Rose Marie Amini
    Department of Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
    BMC Cancer 7:165. 2007
    ..Inflammatory cells in the tumour stroma has gained increasing interest recently. Thus, we aimed to study the frequency and prognostic impact of stromal mast cells and tumour infiltrating eosinophils in invasive breast carcinomas...
  3. ncbi request reprint Relationship between Hodgkin's and non-Hodgkin's lymphomas
    Rose Marie Amini
    Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, Uppsala, Sweden
    Med Oncol 20:211-20. 2003
    ..It is thus possible that a biological relationship between the disorders may exist in addition to morphological overlaps, and the purpose with this review is to summarize the different relations between HL and NHL...
  4. ncbi request reprint A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma
    Rose Marie Amini
    Department of Genetics and Pathology, Uppsala University, Uppsala University Hospital, SE 751 85 Uppsala, Sweden
    Leuk Lymphoma 43:2179-89. 2002
    ..This cell line may become a useful tool to better understand the mechanisms responsible for development of secondary NHL in patients treated for HL...
  5. ncbi request reprint Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival
    Rose Marie Amini
    Department of Genetics and Pathology, University of Uppsala, Sweden
    Leuk Lymphoma 43:1253-60. 2002
    ..We found a significant relation between the expression of p53 and EBV at diagnosis and relapse, indicating a clonal relationship. We were unable to find any specific staining pattern of p53 or Rb, affecting survival...
  6. ncbi request reprint Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
    Ingrid Glimelius
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University Hospital, Uppsala, Sweden
    Eur J Haematol 71:327-33. 2003
    ..In conclusion, we suggest that bulky disease should be taken into account when treating patients with stage IIB HL...
  7. ncbi request reprint Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis
    Mattias Berglund
    Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
    Mod Pathol 18:1113-20. 2005
    ..Here we confirm the prognostic importance of determining the germinal- or nongerminal center phenotype in patients with DLBCL...
  8. ncbi request reprint IL-9 expression contributes to the cellular composition in Hodgkin lymphoma
    Ingrid Glimelius
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
    Eur J Haematol 76:278-83. 2006
    ..The aim of this study was to explore if the expression of IL-9 correlates to the presence of these inflammatory cells in HL tumours...
  9. doi request reprint Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study
    Ingrid Glimelius
    Department of Radiology, Oncology and Radiation Science Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden
    Eur J Haematol 87:208-16. 2011
    ..The aim of this study was to investigate how selected patient characteristics and genetic factors affect HL phenotype, in particular tissue eosinophilia, mast cell counts and HL histological subtype...
  10. doi request reprint Quantitative evaluation of p16(INK4a) promoter methylation using pyrosequencing in de novo diffuse large B-cell lymphoma
    Norafiza Zainuddin
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
    Leuk Res 35:438-43. 2011
    ..048) in patients <65 years old, the significance of this finding, if any, needs to be further investigated. In conclusion, our finding questions the role of p16(INK4a) promoter methylation as a negative prognostic factor in DLBCL...
  11. pmc Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
    Wenjing Zhou
    Department of Surgical Science, Uppsala University, Uppsala, SE 75105, Sweden
    BMC Cancer 10:653. 2010
    ..However, the prognosis of basal-like ductal carcinoma in situ (DCIS) is still unknown. Our aim was to study the prognosis of basal-like DCIS in a large population-based cohort...
  12. ncbi request reprint Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis
    Eva Baecklund
    Department of Rheumatology, Akademiska Hospital, Uppsala, Sweden
    Arthritis Rheum 54:3774-81. 2006
    ..This study was undertaken to investigate whether RA displays a specific association with any of the DLBCL subtypes...
  13. doi request reprint Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma
    Ingrid Glimelius
    Department of Radiology, Oncology and Radiation Science, Uppsala University, Rudbeck Laboratory, Uppsala, Sweden
    Histopathology 61:26-32. 2012
    ..The aim of this study was to compare tissue microarrays (TMA) to whole tissue sections (WS) with regard to cells in the tumour microenvironment. Manual evaluation and digital image analyses (DIA) were utilized and also compared...
  14. doi request reprint Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines
    Ingrid Glimelius
    Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
    Exp Hematol 39:850-8. 2011
    ..Our aim was to investigate the effects of eosinophil cationic protein (ECP) on HL tumor cells in vitro...
  15. doi request reprint TP53 mutations predict for poor survival in de novo diffuse large B-cell lymphoma of germinal center subtype
    Norafiza Zainuddin
    Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
    Leuk Res 33:60-6. 2009
    ..002 and PFS, P=0.006). Neither MDM2 SNP309 nor the TP53 codon 72 polymorphism had an impact on age of onset or survival. Altogether, our data suggests that TP53 mutations are associated with poor outcome in GC-DLBCL patients...
  16. ncbi request reprint Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma
    Gustaf Hedström
    Department of Oncology, Radiology and Clincial Immunology, Uppsala University, Uppsala, Sweden
    Br J Haematol 138:68-71. 2007
    ..03 in both germinal centre (GC) and non-GC DLBCL. This supports the idea that the infiltration of mast cells is a reflection of the host inflammatory response and is related to a favourable outcome...
  17. doi request reprint Low expression of microRNA-129-5p predicts poor clinical outcome in diffuse large B cell lymphoma (DLBCL)
    Gustav Hedström
    Department of Radiology, Oncology, and Radiation Sciences, Uppsala University, Uppsala, Sweden
    Int J Hematol 97:465-71. 2013
    ..Further investigations may also help to elucidate the biological role of microRNA-129-5p in DLBCL...
  18. doi request reprint High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
    Mattias Berglund
    Department of Radiology, Oncology and Radiation Sciences, Uppsala University, Uppsala, Sweden
    Oncol Rep 29:720-4. 2013
    ..Further investigations may also help to elucidate the biological role of microRNA-200c in DLBCL...
  19. ncbi request reprint Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma
    Mattias Berglund
    Department of Molecular Medicine and Surgery, Karolinska University Hospital Solna, Stockholm, Sweden
    Mod Pathol 20:63-75. 2007
    ..The findings support diverse genetic background between transformed and de novo DLBCL...
  20. doi request reprint Cyclin A is a proliferative marker with good prognostic value in node-negative breast cancer
    Cecilia Ahlin
    Department of Oncology, Uppsala University Hospital, SE 751 85 Uppsala, Sweden
    Cancer Epidemiol Biomarkers Prev 18:2501-6. 2009
    ..Studies suggest that cyclin A is a prognostic marker with satisfying reproducibility. We investigated cyclin A as a prognostic marker in node-negative breast cancer using previously defined cutoff values. Patients and..
  21. doi request reprint Neuroendocrine markers are expressed in human mammary glands
    Malin Grönberg
    Dept of Medical Sciences, Section of Endocrine Oncology, Uppsala University, SE 751 85 Uppsala, Sweden
    Regul Pept 160:68-74. 2010
    ..As these peptides are produced by scattered neuroendocrine cells in the epithelium of other tissues the aim of this study was to investigate whether the mammary glands express molecular markers for neuroendocrine cells...
  22. ncbi request reprint Analysis of a clonally related mantle cell and Hodgkin lymphoma indicates Epstein-Barr virus infection of a Hodgkin/Reed-Sternberg cell precursor in a germinal center
    Marianne Tinguely
    Department of Pathology, University of Frankfurt, Germany
    Am J Surg Pathol 27:1483-8. 2003
    ..Importantly, the finding that only a subclone of the HRS clone, defined by a particular mutation pattern, was EBV infected represents a strong indication that EBV infection of the HRS cell precursor happened in the GC...
  23. ncbi request reprint Subtype preference of the BCL6397G/C polymorphism in germinal-center and non-germinal-center subtypes of diffuse large B-cell lymphoma
    Mattias Berglund
    Blood 108:3623-4. 2006
  24. ncbi request reprint Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy
    Heidi Nyman
    Department of Oncology, Helsinki University Central Hospital, FIN 00029 Helsinki, Finland
    Blood 109:4930-5. 2007
    ..030; FFS, 79% vs 52%, P = .028). We conclude that rituximab in combination with chemotherapy seems to eliminate the prognostic value of immunohistochemically defined GC- and non-GC phenotypes in DLBCL...
  25. ncbi request reprint Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma
    Mattias Berglund
    Leuk Lymphoma 48:1038-41. 2007
  26. ncbi request reprint Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study
    Henrik Hjalgrim
    Department of Epidemiology Research, Statens Serum Institut, University of Copenhagen, Artillerivej 5, DK 2300 Copenhagen S, Denmark
    Cancer Epidemiol Biomarkers Prev 16:1561-6. 2007
    ..The conflicting finding may reflect etiologic heterogeneity between HL subtypes, warranting further characterization of the relationship...
  27. doi request reprint Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers
    Kirsimari Aaltonen
    Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland
    Clin Cancer Res 14:1976-83. 2008
    ..Cyclin E expression in tumors of BRCA1 or BRCA2 carriers is higher, and cyclin D1 expression lower, than in sporadic tumors. In familial non-BRCA1/2 tumors, cyclin E and cyclin D1 expression has not been studied...